Risk factors for treatment failure in patients with ventilator-associated pneumonia receiving appropriate antibiotic therapy

Journal of Critical Care

Volumn 23, Issue 1, 2008, Pages 34-40

  Gursel, Gul ^a   Aydogdu, Muge ^a   Ozyilmaz, Ezgi ^a   Ozis, Turkan N ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE;

ADULT; AGED; ANTIBIOTIC THERAPY; APACHE; ARTICLE; BACTEREMIA; CARBOHYDRATE INTAKE; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; INFECTION; INTENSIVE CARE UNIT; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; PREDICTOR VARIABLE; RISK ASSESSMENT; RISK FACTOR; STEROID THERAPY; TRANSFUSION; TREATMENT FAILURE; VENTILATOR ASSOCIATED PNEUMONIA;

AGED; ANTI-BACTERIAL AGENTS; APACHE; CHI-SQUARE DISTRIBUTION; FEMALE; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; TREATMENT FAILURE;

EID: 40949151965     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2007.12.015     Document Type: Article

References (38)

1. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 27 (1999) 520-532
2. Centers for Disease Control and Prevention. Monitoring hospital acquired infections to promote patient safety: United States, 1990-1999. MMWR Morb Mortal Wkly Rep 49 (2000) 149-153
3. American Thoracic Society Documents. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171 (2005) 388-416
4. Gursel G. Determinants of the length of mechanical ventilation in patients with COPD in the intensive care unit. Respiration 72 (2005) 61-67
5. Bercault N., and Boulain T. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case control study. Crit Care Med 29 (2001) 2303-2309
6. Bregeon F., Ciais V., Carret V., et al. Is ventilator-associated pneumonia an independent risk factor for death?. Anesthesiology 94 (2001) 554-560
7. Almirall J., Mesalles E., Klamburg J., et al. Prognostic factors of pneumonia requiring admission to the intensive care unit. Chest 107 (1995) 511-516
8. Kollef M.H., Sherman G., Ward S., et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115 (1999) 462-474
9. Dominguez A.A., Arango M.V., and Torres A. Treatment failure in patients with ventilator-associated pneumonia. Semin Respir Crit Care Med 27 (2006) 104-113
10. Ioanas M., Ferrer M., Cavalcanti M., et al. Causes and predictors of non-response to treatment of intensive care unit-acquired pneumonia. Crit Care Med 32 (2004) 938-945
11. Iregui M., Ward S., Sherman G., et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 122 (2002) 262-268
12. Garnacho-Montero J., Garcia-Garmendia J.L., Barrero-Almodovar A., et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 31 (2003) 2742-2751
13. Combes A., Luyt C.E., Fagon J.Y., et al., for the PNEUMA Trial Group. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia. Crit Care Med 35 (2007) 146-154
14. Calandra T., and Cohen J. International Sepsis Forum Definition of Infection in the ICU Consensus Conference. The International Sepsis Forum Conference on Definitions of Infection in the Intensive Care Unit. Crit Care Med 33 (2005) 1538-1548
15. Van den Berghe G. Beyond diabetes: saving lives with insulin in the ICU. Int J Obesity 26 Suppl 3 (2002) S3-S8
16. Vincent J.L., and Ferreira F.L. Multiple organ failure: clinical syndrome. In: Evans T., and Fink M. (Eds). Update in intensive care and emergency medicine (38). Mechanisms of organ dysfunction in critical illness (2002), Springer-Verlag, Berlin Heidelberg 394-403
17. Members of the American Collage of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. American Collage of Chest Physicians/ Society of Critical Care Medicine Consensus Conference: definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20 (1992) 864-874
18. Pugin J., Auckenthaler R., Mili N., et al. Diagnosis of ventilator associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolaar lavage fluid. Am Rev Respir Dis 143 (1991) 1121-1129
19. Luna C.M., Blanzaco D., Niederman M.S., et al. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 31 (2003) 676-682
20. Luna C.M., and Niederman M.S. What is the natural history of resolution of nosocomial pneumonia?. Sem Resp Crit Care Med 5 (2002) 471-479
21. Luna C.M., Aruj P., Niederman J., et al., for the Grupo Argentino de Estudio de la Neumonia Asociada al Respirador(GANAR) group. Appropriateness and delay to initiate therapy in ventilator associated pneumonia. Eur Res J 27 (2006) 158-164
22. Dennesen P.J., van der Ven A.J., Kessels A.G., et al. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 163 (2001) 1371-1375
23. Montravers P., Fagon J.Y., Chastre J., et al. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am Rev Respir Dis 147 (1993) 38-44
24. Chastre J., Wolff M., Fagon J.Y., et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator associated pneumonia in adults: a randomized trial. JAMA 290 (2003) 2588-2598
25. Gursel G., and Demirtas S. Value of APACHE II, SOFA and CPIS scores in predicting prognosis in patients with ventilator associated pneumonia. Respiration 73 (2006) 503-508
26. Rello J., Jubert P., Valles J., et al. Evaluation of outcome for intubated patients with pneumonia due to P. aeruginosa. Clin Infect Dis 23 (1997) 973-978
27. Leroy O., Meybek A., d'Escrivan T., et al. Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator associated pneumonia. Intensive Care Med 29 (2003) 2170-2173
28. Froon A.H., Bonten M., Gaillard C.A., et al. Prediction of clinical severity and outcome of ventilator associated pneumonia. Comparison of simplified acute physiology score with systemic inflammatory mediators. Am J Respir Crit Care Med 158 (1998) 1026-1031
29. Long C., Kinney J., and Geiger J. Nonsupressibility of gluconeogenesis by glucose in septic patients. Metabolism 25 (1976) 193-201
30. Leverve X., Barnoud D., and Pichard C. Nutritional support in acute respiratory failure. From Nutritional support to pharmacologic nutrition in the ICU. Update in intensive care and emergency medicine 34 (2000), Springer-Verlag, Berlin Heidelberg 303-315
31. Krishnan J.A., Paice P.B., Martinez S., et al. Caloric intake in medical ICU patients: consistency of care with guidelines and relationship to clinical outcomes. Chest 124 (2003) 297-305
32. Le Tulzo Y., Pangault C., Gacouin A., et al. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock 18 (2002) 487-494
33. Hotchkiss R.S., Chang K.C., Grayson M.H., et al. Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc Natl Acad Sci U S A 100 (2003) 6724-6729
34. Schreiber T., Swanson P.E., Chang K.C., et al. Both Gram-negative and gram-positive experimental pneumonia induce profound lymphocyte but not respiratory epithelial cell apoptosis. Shock 26 (2006) 271-276
35. Combes A., Luyt C.E., Fagon J.Y., et al. Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator associated pneumonia. Am J Respir Crit Care Med 170 (2004) 786-792
36. Trouillet J.L., Vuagnat A., Combes A., et al. Pseudomonas aeruginosa ventilator associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms. Clin Infect Dis 34 (2002) 1047-1054
37. Pittet D., Woolson R.F., and Wenzel R.P. Microbiological factors influencing the outcome nosocomial bloodstream infection: a 6 year, validated population-based model. Clin Infect Dis 24 (1997) 1068-1078
38. Luna C., Videla A., Matera J., et al. Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in VAP. Chest 116 (1999) 1075-1084